ANA (Antinuclear Antibody)

BUN (Blood Urea Nitrogen)

RBC Magnesium

Total Protein

DHA (Docosahexaenoic Acid)

MCHC (Mean Corpuscular Hemoglobin Concentration)

Basophils (Absolute)

Iron Saturation

LDL Particle Number

Cystatin C

LDL Particle Size

Tg Ab (Thyroglobulin Antibodies)

Free T4 (Thyroxine)

Albumin

Apolipoprotein A1

Immature Granulocytes

Apolipoprotein B

TIBC (Total Iron Binding Capacity)

A/G Ratio (Albumin/Globulin Ratio)

Neutrophils (Absolute)

BUN/Creatinine Ratio

Calcium

IL-6 (Interleukin-6)

Fasting Insulin

Ceruloplasmin

MCH (Mean Corpuscular Hemoglobin)

ALT (Alanine Aminotransferase)

TSH (Thyroid Stimulating Hormone)

TNF-α (Tumor Necrosis Factor-alpha)

Monocytes (Absolute)

Sodium

eGFR (Estimated Glomerular Filtration Rate)

DHEA-S (Dehydroepiandrosterone Sulfate)

AST (Aspartate Aminotransferase)

Glucose

Lymphocytes (Absolute)

ApoA/ApoB Ratio

Chloride

RDW (Red Cell Distribution Width)

Eosinophils (Absolute)

Apolipoprotein A1 is a biomarker used in longevity research to assess cardiovascular health and predict risk of age-related diseases.

Apolipoprotein A1

Apolipoprotein A1 is a critical biomarker used in assessing the risk of cardiovascular diseases and overall longevity. It is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases and are considered a favorable biomarker for longevity. Studies have shown that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Thus, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life.

Biomarker Explained

Apolipoprotein A1 is a crucial biomarker used in assessing an individual’s potential for longevity. This biomarker is a major component of high-density lipoprotein (HDL) particles and plays a central role in the reverse cholesterol transport pathway. Higher levels of Apolipoprotein A1 are associated with a reduced risk of developing heart diseases, making it a favorable biomarker for longevity. Studies have demonstrated that individuals with higher Apolipoprotein A1 levels tend to live longer and have better cardiovascular health. Therefore, monitoring Apolipoprotein A1 levels can provide valuable insights into an individual’s potential for living a longer and healthier life. Assessing the levels of Apolipoprotein A1 in an individual’s blood can help predict their risk of cardiovascular diseases and overall longevity. It is essential to consider this biomarker in combination with other relevant factors to gain a comprehensive understanding of an individual’s potential for longevity.

Keywords:

Apolipoprotein A1, longevity, biomarker, high-density lipoprotein (HDL), reverse cholesterol transport, cardiovascular health, potential for living longer

Complete Patient Intake Form

Continue Browsing Our Offers